Abstract
2529 Background: Myelosuppression is the major dose-limiting toxicity of chemotherapy, which limits dose intensity. G1T28 is a highly potent and selective CDK4/6 inhibitor in development as an IV a...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
